| 20761-3 |
Clostridioides difficile |
PrThr |
Stool |
Pt |
Ord |
Aggl |
|
ACTIVE |
Clostridioides difficile [Presence] in Stool by Agglutination |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20761-3 |
|
Aggl |
|
|
Both |
|
|
|
0 |
C diff Stl Ql Aggl |
|
|
|
|
|
Agg; Agglut; Agglutination; Bowel movement; C diff; C difficile; Clostridium difficile; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal; UniversalLabOrders |
2.73 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016; Updated Component from Clostridium to Clostridioides based on current accepted nomenclature for this genus [PMID:27370902]. |
0 |
| 20762-1 |
Clostridioides difficile |
PrThr |
Stool |
Pt |
Ord |
Aerobic culture |
|
ACTIVE |
Clostridioides difficile [Presence] in Stool by Aerobe culture |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20762-1 |
|
Aerobic culture |
|
|
Both |
|
|
|
0 |
C diff Stl Ql Aerobe Cult |
|
|
|
|
|
Aerobe; Aerobe Cult; Aerobed; Bowel movement; C diff; C difficile; C&S; Clostridium difficile; Cult; Cultures; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal |
2.73 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016; Updated genus name from Clostridium to Clostridioides based on current accepted nomenclature for this genus [PMID:27370902]. |
0 |
| 20763-9 |
Clostridium novyii Ag |
PrThr |
Tiss |
Pt |
Ord |
IF |
|
ACTIVE |
Clostridium novyii Ag [Presence] in Tissue by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20763-9 |
|
IF |
|
|
Both |
|
|
|
0 |
C novyii Ag Tiss Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; C novyii; DFA; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20764-7 |
Clostridium perfringens genotype |
Prid |
Isolate |
Pt |
Nom |
|
|
ACTIVE |
Clostridium perfringens genotype [Identifier] in Isolate |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20764-7 |
|
|
|
|
Both |
|
|
|
0 |
C perfringens Gentyp Islt |
|
|
|
|
|
C perfringens; Gentyp; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Random |
2.72 |
1.0m |
|
|
|
|
|
|
|
|
|
|
Added an answer list for C. perfringens genotypes |
0 |
| 20765-4 |
Clostridium septicum Ag |
PrThr |
Tiss |
Pt |
Ord |
IF |
|
ACTIVE |
Clostridium septicum Ag [Presence] in Tissue by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20765-4 |
|
IF |
|
|
Both |
|
|
|
0 |
C septicum Ag Tiss Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; C septicum; DFA; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20766-2 |
Clostridium sordellii Ag |
PrThr |
Tiss |
Pt |
Ord |
IF |
|
ACTIVE |
Clostridium sordellii Ag [Presence] in Tissue by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20766-2 |
|
IF |
|
|
Both |
|
|
|
0 |
C sordellii Ag Tiss Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; C sordellii; DFA; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20767-0 |
Coccidioides immitis |
PrThr |
Isolate |
Pt |
Ord |
|
|
ACTIVE |
Coccidioides immitis [Presence] in Isolate |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20767-0 |
|
|
|
|
Both |
|
|
|
0 |
C immitis Islt Ql |
|
|
|
|
|
B immitis; Blastomycoides immitis; C esteriformis; C immitis; Coccidioides esteriformis; Coccidiomycosis; Coccio; G immite; G louisianoideum; G metaeuropea; Geotrichum immite; Glenospora metaeuropea; Glenosporum louisianoideum; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Ordinal; P esteriformis; P mazzai; Point in time; Posadasia esteriformis; PR; Pseudococcidioides mazzai; QL; Qual; Qualitative; Random; San Joaquin Valley fever; Screen; T proteolyticum; Trichosporon proteolyticum; Valley fever |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20768-8 |
Coccidioides immitis Ab |
PrThr |
Ser |
Pt |
Ord |
Comp fix |
|
ACTIVE |
Coccidioides immitis Ab [Presence] in Serum by Complement fixation |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20768-8 |
|
Comp fix |
|
|
Both |
|
|
|
0 |
C immitis Ab Ser Ql CF |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B immitis; Blastomycoides immitis; C esteriformis; C immitis; CF; Coccidioides esteriformis; Coccidiomycosis; Coccio; Comp fixation; Compfix; Complement fixation; G immite; G louisianoideum; G metaeuropea; Geotrichum immite; Glenospora metaeuropea; Glenosporum louisianoideum; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; P esteriformis; P mazzai; Point in time; Posadasia esteriformis; PR; Pseudococcidioides mazzai; QL; Qual; Qualitative; Random; San Joaquin Valley fever; Screen; Serum; SR; T proteolyticum; Trichosporon proteolyticum; Valley fever |
2.73 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20769-6 |
Coliform bacteria |
NCnc |
Water |
Pt |
Qn |
Viability count |
|
ACTIVE |
Coliform bacteria [#/volume] in Water by Viability count |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20769-6 |
|
Viability count |
|
|
Both |
|
|
|
0 |
Coliform # Wat Viab Cnt |
|
|
|
Y |
|
#; ABS; absolute; absolutes; Bact; Cnt; Count; Count/volume; CT; ID; Infectious Disease; InfectiousDisease; Microbiology; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Viab Cnt; Wat |
2.19 |
1.0m |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 2077-6 |
Chloride |
SCnc |
Sweat |
Pt |
Qn |
|
|
ACTIVE |
Chloride [Moles/volume] in Sweat |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
2077-6 |
|
|
|
|
Both |
|
|
|
0 |
Chloride Sweat-sCnc |
|
|
|
Y |
|
Chemistry; Cl; Cl-; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; SWT; UniversalLabOrders |
2.73 |
1 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
| 20770-4 |
Coliform bacteria |
NCnc |
Envir |
Pt |
Qn |
Viability count |
|
ACTIVE |
Coliform bacteria [#/volume] by Viability count |
|
MIN |
DefinitionDescription |
|
|
/mL |
|
|
|
|
|
|
MICRO |
|
20770-4 |
|
Viability count |
|
|
Both |
|
|
|
0 |
Coliform # Viab Cnt |
|
|
|
Y |
|
#; ABS; absolute; absolutes; Bact; Cnt; Count; Count/volume; CT; ID; Infectious Disease; InfectiousDisease; Microbiology; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Viab Cnt |
2.42 |
1.0m |
|
|
|
|
|
|
|
/mL |
|
|
|
0 |
| 20771-2 |
Coliform bacteria |
NCnt |
Egg |
Pt |
Qn |
Viability count |
|
ACTIVE |
Coliform bacteria [#/mass] in Egg by Viability count |
|
MIN |
DefinitionDescription |
|
|
CFU/g |
|
|
|
|
|
|
MICRO |
|
20771-2 |
|
Viability count |
|
|
Both |
|
|
|
0 |
Coliform Egg Viab Cnt |
|
|
|
Y |
|
Bact; Count/mass; Eggs; ID; Infectious Disease; InfectiousDisease; Microbiology; Number content; Point in time; QNT; Quan; Quant; Quantitative; Random; Viab Cnt |
2.66 |
1.0m |
|
|
|
|
|
|
|
/g |
|
|
|
0 |
| 20772-0 |
Coliform colony count |
NCnc |
Milk |
Pt |
Qn |
|
|
ACTIVE |
Coliform colony count [#/volume] in Milk |
|
MIN |
DefinitionDescription |
|
|
/mL |
|
|
|
|
|
|
MICRO |
|
20772-0 |
|
|
|
|
Both |
|
|
|
0 |
Coliform CC # Mlk |
|
|
|
Y |
|
#; ABS; absolute; absolutes; CC; Cnt; Coliform CC; Colonies; Count; Count/volume; CT; ID; Infectious Disease; InfectiousDisease; Microbiology; Mlk; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random |
2.42 |
1.0m |
|
|
|
|
|
|
|
/mL |
|
|
|
0 |
| 20773-8 |
Colony count |
NCnc |
Milk |
Pt |
Qn |
Culture.standard plate count |
|
ACTIVE |
Colony count [#/volume] in Milk by Culture Standard Plate Count |
|
MIN |
DefinitionDescription |
|
|
/mL |
|
|
|
|
|
|
MICRO |
|
20773-8 |
|
Culture.standard plate count |
|
|
Both |
|
|
|
0 |
CC # Mlk Cult Std Plate Cnt |
|
|
|
Y |
|
#; ABS; absolute; absolutes; C&S; CC; Cnt; Colonies; Count; Count/volume; CT; Cult; Cult Std Plate Cnt; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Mlk; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random |
2.42 |
1.0m |
|
|
|
|
|
|
|
/mL |
|
|
|
0 |
| 20774-6 |
Colony count |
ACnc |
XXX |
Pt |
Qn |
VC |
|
ACTIVE |
Colony count [Units/volume] in Specimen by Visual count |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20774-6 |
|
VC |
|
|
Both |
|
|
|
0 |
CC Spec VC-aCnc |
|
|
|
Y |
|
Arbitrary concentration; CC; Colonies; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Visual count |
2.73 |
1.0m |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 20775-3 |
Colony count |
ACnc |
XXX |
Pt |
Qn |
Viability count.FDA method |
|
ACTIVE |
Colony count [Units/volume] in Specimen by Viability count FDA method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20775-3 |
|
Viability count.FDA method |
|
|
Both |
|
|
|
0 |
CC Spec Viab Cnt FDA-aCnc |
|
|
|
Y |
|
Arbitrary concentration; CC; Colonies; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Viab Cnt; Viab Cnt FDA |
2.69 |
1.0m |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 20776-1 |
Caprine parapoxvirus Ab |
PrThr |
Tiss |
Pt |
Ord |
IF |
|
ACTIVE |
Caprine parapoxvirus Ab [Presence] in Tissue by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20776-1 |
|
IF |
|
|
Both |
|
|
|
0 |
Caprine Parapox Ab Tiss Ql IF |
|
|
|
|
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Parapox virus; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20777-9 |
Caprine parapoxvirus Ab |
PrThr |
Ser |
Pt |
Ord |
Comp fix |
|
ACTIVE |
Caprine parapoxvirus Ab [Presence] in Serum by Complement fixation |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20777-9 |
|
Comp fix |
|
|
Both |
|
|
|
0 |
Caprine Parapox Ab Ser Ql CF |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Parapox virus; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20778-7 |
Copper |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Copper [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/dL |
|
|
|
|
|
|
DRUG/TOX |
|
20778-7 |
|
|
|
|
Both |
|
|
|
0 |
Copper Spec-mCnc |
|
|
|
Y |
|
Cu; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified |
2.73 |
1.0m |
|
|
|
|
|
|
|
ug/dL |
|
|
|
0 |
| 20779-5 |
Bovine coronavirus Ag |
PrThr |
Tiss |
Pt |
Ord |
IF |
|
ACTIVE |
Bovine coronavirus Ag [Presence] in Tissue by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20779-5 |
|
IF |
|
|
Both |
|
|
|
0 |
BCV Ag Tiss Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; BCV; Beef; Corona virus; DFA; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 2078-4 |
Chloride |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Chloride [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
2078-4 |
|
|
|
|
Both |
|
|
|
0 |
Chloride Ur-sCnc |
|
|
|
Y |
|
Chemistry; Cl; Cl-; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UniversalLabOrders; UR; Urn |
2.73 |
1 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
197 |
| 20780-3 |
Cryptosporidium sp |
PrThr |
Tlgi/Tsmi |
Pt |
Ord |
Acid fast stain |
|
ACTIVE |
Cryptosporidium sp [Presence] in Large intestine or small intestine Tissue by Acid fast stain |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20780-3 |
|
Acid fast stain |
|
|
Both |
|
|
|
0 |
Cryptosp TLGI/TSMI Ql Acid fast Stn |
|
|
|
|
|
Acd; Acid fast Stn; Acids; AFB stain; Crypt; Crypto; Cryptosporidiosis; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; St; Stains; Stn; Tissue large intestine; Tissue small intestine |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20781-1 |
Cryptosporidium sp |
PrThr |
Stool |
Pt |
Ord |
Acid fast stain |
|
ACTIVE |
Cryptosporidium sp [Presence] in Stool by Acid fast stain |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20781-1 |
|
Acid fast stain |
|
|
Both |
|
|
|
0 |
Cryptosp Stl Ql Acid fast Stn |
|
|
|
|
|
Acd; Acid fast Stn; Acids; AFB stain; Bowel movement; Crypt; Crypto; Cryptosporidiosis; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; St; Stains; Stl; Stn; Stool = Fecal; UniversalLabOrders |
2.73 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20782-9 |
Cyanide |
MCnt |
Plant |
Pt |
Qn |
|
|
ACTIVE |
Cyanide [Mass/mass] in Plant |
|
MIN |
DefinitionDescription |
|
|
mg/g |
|
|
|
|
|
|
DRUG/TOX |
|
20782-9 |
|
|
|
|
Both |
|
|
|
0 |
Cyanide Plant-mCnt |
|
|
|
Y |
|
CN; DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.42 |
1.0m |
|
|
|
|
|
|
|
mg/g |
|
|
|
0 |
| 20783-7 |
Cyanide |
ACnt |
Plant |
Pt |
Ord |
|
|
ACTIVE |
Cyanide [Units/mass] in Plant Qualitative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
20783-7 |
|
|
|
|
Both |
|
|
|
0 |
Cyanide Plant Ql |
|
|
|
|
|
Arbitrary content; CN; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen |
2.07 |
1.0m |
|
|
|
|
|
|
|
|
|
|
|
0 |
